Transforming discovery through genomics, proteomics, and AI-driven biological intelligence.
PanAUM™ redefines the future of drug discovery by integrating genomics, transcriptomics, proteomics, metabolomics, microbiomics, and exposomics into one unified AI platform. Unlike traditional models limited to chemical or single-omic data, PanAUM decodes the full biological landscape of disease, revealing actionable targets that conventional systems miss.
Powered by a proprietary inference engine and cross-validated multiomics datasets, PanAUM™ predicts true disease drivers, models drug response and toxicity, and maps precision cohorts for translational accuracy. Its self-learning algorithms evolve with every dataset, bridging computational insights and clinical validation.
PanAUM™ empowers researchers and biotech innovators to accelerate discovery, improve patient stratification, and reduce failure rates in clinical trials turning biological complexity into therapeutic clarity.
Learn More
Explore genomic sequencing and genetic DNA testing for health in Calgary and across Canada with BioAro. Unlock genetic insights today.
BioAro services are offered worldwide.
